Strumento inattivo

Altre lingue Pain Therapeutics, Inc. Nasdaq

Azioni

Cassava Sciences forms internal panel after US probe into two employees	01/07
Cassava Sciences forms internal committee after probes by U.S. regulators into two employees	01/07
Top Premarket Gainers	01/07
Profesor estadounidense, acusado de manipular datos para un ensayo de un fármaco contra el Alzheimer	29/06
Health Care Stocks Slip -- Health Care Roundup	28/06
Cassava Sciences' Shares Down 46% After Adviser Is Indicted	28/06
Cassava Sciences Issues Statement on Former Science Advisor	28/06
US professor charged with manipulating data for Alzheimer's drug trial	28/06
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam	13/05
Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam	10/05
Cassava Sciences Raises More Than $125 Million From Warrant Distribution	08/05
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution	08/05
North American Morning Briefing : Stock Futures -2-	06/05
Cassava Sciences : Warrants – Notice of Guaranteed Delivery	02/05
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ	01/05
North American Morning Briefing : Investors Brace -2-	29/04
Cassava Sciences : Corporate Presentation – Second Quarter 2024	24/04
Cassava Sciences, Inc. - Redemption Date Announced for Warrants	16/04
Redemption Date Announced for Warrants	15/04

Non ci sono risultati per questa ricerca